2023-02-27 |
2022-11-28 |
V
Vente
|
HEALY JAMES
Administrateur non-exécutif
Large shareholder
|
6 000
-100.0%
14,32
85 920
USD
|
6 000
-100.0%
|
14,32
|
85 920
USD
|
|
2022-08-17 |
2022-08-15 |
A
Achat
|
5AM Partners VI, LLC
Large shareholder
|
487 333
+inf%
30,00
14 619 990
USD
|
487 333
+inf%
|
30,00
|
14 619 990
USD
|
|
2022-08-17 |
2022-08-15 |
A
Achat
|
5AM Partners VI, LLC
Large shareholder
|
112 667
+2.9%
30,00
3 380 010
USD
|
112 667
+2.9%
|
30,00
|
3 380 010
USD
|
|
2022-08-17 |
2022-08-15 |
A
Achat
|
Sofinnova Partners SAS
Large shareholder
|
133 333
+3.3%
30,00
3 999 990
USD
|
133 333
+3.3%
|
30,00
|
3 999 990
USD
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.
Large shareholder
|
83 000
+2.0%
30,00
2 490 000
USD
|
83 000
+2.0%
|
30,00
|
2 490 000
USD
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
Sofinnova Venture Partners X, L.P.
Large shareholder
|
500 000
+9.0%
30,00
15 000 000
USD
|
500 000
+9.0%
|
30,00
|
15 000 000
USD
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
GENERAL ATLANTIC, L.P.
Large shareholder
|
83 000
+2.0%
30,00
2 490 000
USD
|
83 000
+2.0%
|
30,00
|
2 490 000
USD
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
Large shareholder
|
6 000
+inf%
30,00
180 000
USD
|
6 000
+inf%
|
30,00
|
180 000
USD
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
Large shareholder
|
500 000
+9.0%
30,00
15 000 000
USD
|
500 000
+9.0%
|
30,00
|
15 000 000
USD
|
|
2023-02-27 |
2022-06-10 |
V
Vente
|
Freeman Mason
Chief Medical Officer
Dirigeant
|
6
-0.2%
15,21
91
USD
|
6
-0.2%
|
15,21
|
91
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Coelho Mary Theresa
EVP CFO & Chief BD Officer
Dirigeant
|
100
+inf%
16,00
1 600
USD
|
100
+inf%
|
16,00
|
1 600
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Sofinnova Venture Partners X, L.P.
Large shareholder
|
325 000
+6.2%
16,00
5 200 000
USD
|
325 000
+6.2%
|
16,00
|
5 200 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
Large shareholder
|
325 000
+6.2%
16,00
5 200 000
USD
|
325 000
+6.2%
|
16,00
|
5 200 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Sofinnova Partners SAS
Large shareholder
|
220 000
+5.7%
16,00
3 520 000
USD
|
220 000
+5.7%
|
16,00
|
3 520 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
5AM Partners VI, LLC
Large shareholder
|
312 500
+170.0%
16,00
5 000 000
USD
|
312 500
+170.0%
|
16,00
|
5 000 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
5AM Partners VI, LLC
Large shareholder
|
157 500
+4.3%
16,00
2 520 000
USD
|
157 500
+4.3%
|
16,00
|
2 520 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.
Large shareholder
|
1 700 000
+70.1%
16,00
27 200 000
USD
|
1 700 000
+70.1%
|
16,00
|
27 200 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
de Garidel Marc
Chief Executive Officer
Administrateur exécutif
|
12 500
+inf%
16,00
200 000
USD
|
12 500
+inf%
|
16,00
|
200 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Pearce Catherine
Chief Operating Officer
Dirigeant
|
1 500
+inf%
16,00
24 000
USD
|
1 500
+inf%
|
16,00
|
24 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Pearce Catherine
Chief Operating Officer
Dirigeant
|
750
+0.6%
16,00
12 000
USD
|
750
+0.6%
|
16,00
|
12 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Freeman Mason
EVP Clinical Development
Dirigeant
|
100
+inf%
16,00
1 600
USD
|
100
+inf%
|
16,00
|
1 600
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Freeman Mason
EVP Clinical Development
Dirigeant
|
2 500
+inf%
16,00
40 000
USD
|
2 500
+inf%
|
16,00
|
40 000
USD
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
GENERAL ATLANTIC, L.P.
Large shareholder
|
1 700 000
+70.1%
16,00
27 200 000
USD
|
1 700 000
+70.1%
|
16,00
|
27 200 000
USD
|
|